KELSIE CHERISSE FAGARAGAN: Open Payments
NPI 1336926914 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 11 payments from 8 companies in 2025. Trend: 2023 $244 · 2024 $29 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $177 |
| Lilly USA, LLC | 1 | $113 |
| Amgen Inc. | 2 | $43 |
| Boston Scientific Corporation | 1 | $26 |
| MIMEDX Group, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| Intra-Sana Laboratories | 1 | $14 |
Products named: AIRSUPRA, JARDIANCE, General - Pain Management, REPATHA, OTEZLA, Rybelsus, NURTEC ODT, RELTONE 200 MG.
Industry payments across NV — which companies pay providers there.
